United States: OPDP Issues Final Guidance On Best Practices For Presenting Quantitative Efficacy And Risk Information In Direct-To-Consumer Promotional Labeling And Advertisements - Foley Hoag LLP
On June 27, 2023, the Food and Drug Administration's ("FDA") Office of Prescription Drug Promotion ("OPDP") published a final guidance (the "Final Guidance") on Presenting Quantitative Efficacy...
Full Article